A view that puberty blocker use for trans youth in New Zealand needs tighter supervision.
New Zealand's use of puberty blockers is seven times higher than comparable countries.
Paediatric Endocrinologist, Paul Hofman says they shouldn't be banned as they can be effective in some cases.
He told Heather du Plessis-Allan it's not settled science.
Hofman says the evidence for puberty blocker's efficacy is not as strong as many think.
LISTEN ABOVE

Gavin Grey: UK correspondent on Labour's poor showing at the local elections
03:41

Geoff Bertram: energy economist on the Greens calling for the Government to bring down power prices
05:43

Shane Solly: Harbour Asset Management expert on the market reactions to the 'no deal' announcement on the Middle East conflict
03:07